Published in Infect Immun on February 01, 1985
Bordetella pertussis filamentous hemagglutinin: evaluation as a protective antigen and colonization factor in a mouse respiratory infection model. Infect Immun (1990) 2.89
A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis. Infect Immun (1998) 2.02
Infection of newborn piglets with Bordetella pertussis: a new model for pertussis. Infect Immun (2005) 0.95
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues. J Immunol (1979) 5.55
Development of a pertussis component vaccine in Japan. Lancet (1984) 3.94
Prospective studies of the effect of breast feeding on incidence of infection and allergy. Acta Paediatr Scand (1979) 3.55
Pertussis toxin: the cause of the harmful effects and prolonged immunity of whooping cough. A hypothesis. Rev Infect Dis (1980) 3.34
Morbidity in breast-fed and artificially fed infants. II. J Pediatr (1979) 3.00
Breast-feeding protects against respiratory syncytial virus infections. Br Med J (1976) 2.98
Separation and purification of the hemagglutinins from Bordetella pertussis. Infect Immun (1983) 2.85
Role of antibody to leukocytosis-promoting factor hemagglutinin and to filamentous hemagglutinin in immunity to pertussis. Infect Immun (1981) 2.77
Antigenic relationship between serotype-specific agglutinogen and fimbriae of Bordetella pertussis. Infect Immun (1982) 2.28
Anti-infective properties of breast milk. J Pediatr (1979) 1.97
Protective activities of the filamentous hemagglutinin and the lymphocytosis-promoting factor of Bordetella pertussis in mice. J Infect Dis (1984) 1.96
Bordetella pertussis toxins. Pharmacol Ther (1982) 1.93
Serological response to filamentous hemagglutinin and lymphocytosis-promoting toxin of Bordetella pertussis. Infect Immun (1983) 1.77
Antibacterial and antitoxin responses in the serum and milk of cholera patients. Infect Immun (1981) 1.56
Structure and function of mucosal antibodies. Annu Rev Med (1970) 1.46
Antibody production by human colostral cells. I. Immunoglobulin class, specificity, and quantity. Scand J Immunol (1975) 1.43
Breast-feeding and Salmonella infection. Am J Dis Child (1980) 1.21
Antimicrobial factors in human milk. Studies of concentration and transfer to the infant during the early stages of lactation. Acta Paediatr Scand Suppl (1978) 1.15
In vitro inhibition of murine macrophage migration by Bordetella pertussis lymphocytosis-promoting factor. Infect Immun (1984) 1.12
Transplacental and transcolostral immunity to pertussis in a mouse model using acellular pertussis vaccine. J Infect Dis (1983) 1.06
Metabolism of immunoglobulin A in lactating mice: origins of immunoglobulin A in milk. Eur J Immunol (1982) 1.05
Protective properties of anticholera antibodies in human colostrum. Infect Immun (1982) 0.98
Duration of anti-adhesive and bactericidal activities of milk from vaccinated sows on Escherichia coli O149 in the digestive tract of piglets during the nursing period. Res Vet Sci (1979) 0.89
Chlamydial secretory IgA antibodies in human milk. Acta Pathol Microbiol Immunol Scand C (1982) 0.79
Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics (1981) 7.58
Induction of a novel morphological response in Chinese hamster ovary cells by pertussis toxin. Infect Immun (1983) 5.03
Extracytoplasmic adenylate cyclase of Bordetella pertussis. Proc Natl Acad Sci U S A (1976) 3.57
Pertussis toxin. Affinity purification of a new ADP-ribosyltransferase. J Biol Chem (1983) 3.31
Bordetella pertussis filamentous hemagglutinin: evaluation as a protective antigen and colonization factor in a mouse respiratory infection model. Infect Immun (1990) 2.89
Separation and purification of the hemagglutinins from Bordetella pertussis. Infect Immun (1983) 2.85
Role of antibody to leukocytosis-promoting factor hemagglutinin and to filamentous hemagglutinin in immunity to pertussis. Infect Immun (1981) 2.77
Identification of a 69-kilodalton nonfimbrial protein as an agglutinogen of Bordetella pertussis. Infect Immun (1988) 2.55
ADP-ribosylation of transducin by pertussis toxin blocks the light-stimulated hydrolysis of GTP and cGMP in retinal photoreceptors. J Biol Chem (1984) 2.39
Aerosol infection of mice with Bordetella pertussis. Infect Immun (1980) 2.31
Phase-shift markers in Bordetella: alterations in envelope proteins. J Infect Dis (1981) 2.23
Filamentous hemagglutinin has a major role in mediating adherence of Bordetella pertussis to human WiDr cells. Infect Immun (1986) 2.18
Location of the corticospinal tract in the internal capsule at MR imaging. Radiology (1994) 2.12
Clinical analysis and prognostic study of ossified ligamentum flavum of the thoracic spine. J Neurosurg (2001) 2.04
Protective activities of the filamentous hemagglutinin and the lymphocytosis-promoting factor of Bordetella pertussis in mice. J Infect Dis (1984) 1.96
Sensitivity and specificity of clinical case definitions for pertussis. Am J Public Health (1988) 1.93
Comparison of type 2 and type 6 fimbriae of Bordetella pertussis by using agglutinating monoclonal antibodies. Infect Immun (1988) 1.92
Lectin-like binding of pertussis toxin to a 165-kilodalton Chinese hamster ovary cell glycoprotein. J Biol Chem (1988) 1.88
Intracellular localization of the dermonecrotic toxin of Bordetella pertussis. Infect Immun (1979) 1.83
Serological response to filamentous hemagglutinin and lymphocytosis-promoting toxin of Bordetella pertussis. Infect Immun (1983) 1.77
Energetics of glycylglycine transport in Escherichia coli. J Bacteriol (1974) 1.76
Agglutinating monoclonal antibodies that specifically recognize lipooligosaccharide A of Bordetella pertussis. Infect Immun (1988) 1.71
Immunologic response to early and routine DTP immunization in infants. Pediatrics (1984) 1.71
Binding of pertussis toxin to eucaryotic cells and glycoproteins. Infect Immun (1989) 1.71
Pertussis toxin substrate, the putative Ni component of adenylyl cyclases, is an alpha beta heterodimer regulated by guanine nucleotide and magnesium. Proc Natl Acad Sci U S A (1983) 1.67
Characterization of the protective capacity and immunogenicity of the 69-kD outer membrane protein of Bordetella pertussis. J Exp Med (1990) 1.67
Infants and children with convulsions and hypotonic-hyporesponsive episodes following diphtheria-tetanus-pertussis immunization: follow-up evaluation. Pediatrics (1988) 1.66
Ns and Ni, the stimulatory and inhibitory regulatory components of adenylyl cyclases. Purification of the human erythrocyte proteins without the use of activating regulatory ligands. J Biol Chem (1984) 1.62
Superior outcome of infant acute myeloid leukemia with intensive chemotherapy: results of the Japan Infant Leukemia Study Group. Blood (2001) 1.61
Stimulation and inhibition of adenylyl cyclases mediated by distinct regulatory proteins. Nature (1983) 1.59
Nonfermentative bacilli associated with man. I. Nomenclature. Am J Clin Pathol (1970) 1.57
ADP-ribosyltransferase activity of pertussis toxin and immunomodulation by Bordetella pertussis. Science (1988) 1.57
Hypercalcemia in childhood acute lymphoblastic leukemia: frequent implication of parathyroid hormone-related peptide and E2A-HLF from translocation 17;19. Leukemia (2006) 1.56
Role of the A subunit of pertussis toxin in alteration of Chinese hamster ovary cell morphology. Infect Immun (1987) 1.52
Three-dimensional monitor in endoscopic surgery. Surg Endosc (2004) 1.51
Identification of Bordetella pertussis infection by shared-primer PCR. J Clin Microbiol (1994) 1.49
Evaluation of mixtures of purified Haemophilus influenzae outer membrane proteins in protection against challenge with nontypeable H. influenzae in the chinchilla otitis media model. Infect Immun (1993) 1.47
Purification and characterization of fimbriae isolated from Bordetella pertussis. Infect Immun (1985) 1.47
The X gene of hepatitis B virus induced growth stimulation and tumorigenic transformation of mouse NIH3T3 cells. Jpn J Cancer Res (1989) 1.45
Bronchial sleeve resection with complete preservation of the lung for carcinoma. Respiration (2001) 1.44
A single nucleotide polymorphism of dopamine transporter gene is associated with Parkinson's disease. Ann Neurol (2000) 1.43
Monoclonal antibodies to pertussis toxin: utilization as probes of toxin function. Hybridoma (1989) 1.43
Alteration by cereolysin of the structure of cholesterol-containing membranes. Biochim Biophys Acta (1978) 1.40
Ultrastructure of bile canaliculi, with special reference to the surface coat and the pericanalicular web. Lab Invest (1974) 1.39
Expression of phosphotyrosine and SNAP-25 immunoreactivity in grumose (foamy) spheroid bodies suggests axonal regeneration. Acta Neuropathol (1998) 1.39
Abundance of Virus-Sized Non-DNase-Digestible DNA (Coated DNA) in Eutrophic Seawater. Appl Environ Microbiol (1993) 1.38
A comparison of laboratory and clinical methods for diagnosing pertussis in an outbreak in a facility for the developmentally disabled. J Infect Dis (1988) 1.37
Structural characterization of pertussis toxin A subunit. J Biol Chem (1987) 1.36
Immune response to the B oligomer of pertussis toxin. Infect Immun (1987) 1.36
Serum midkine levels are increased in patients with various types of carcinomas. Br J Cancer (2000) 1.34
Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer. Clin Cancer Res (1996) 1.33
Epitopes on the S1 subunit of pertussis toxin recognized by monoclonal antibodies. Infect Immun (1989) 1.32
Revised assignment for the Bacillus subtilis spo0F gene and its homology with spo0A and with two Escherichia coli genes. Nucleic Acids Res (1986) 1.30
Placentomegaly in cloned mouse concepti caused by expansion of the spongiotrophoblast layer. Biol Reprod (2001) 1.26
The significance of roentgenographic measurement in scoliosis. J Pediatr Orthop (1982) 1.26
Pertussis encephalopathy with a normal brain biopsy and elevated lymphocytosis-promoting factor antibodies. Pediatr Infect Dis (1984) 1.25
Pertussis toxin inhibition of chemotaxis and the ADP-ribosylation of a membrane protein in a human-mouse hybrid cell line. Proc Natl Acad Sci U S A (1985) 1.24
Visuospatial imagery is a fruitful strategy for the digit span backward task: a study with near-infrared optical tomography. Brain Res Cogn Brain Res (2000) 1.21
A sporadic juvenile case of the amyotrophic lateral sclerosis with neuronal intracytoplasmic inclusions. Acta Neuropathol (1978) 1.20
Pertussis toxin analog with reduced enzymatic and biological activities is a protective immunogen. Infect Immun (1990) 1.19
A clinicopathologic study of resected cases of adenosquamous carcinoma of the lung. Chest (1996) 1.17
Purification of cereolysin and the electrophoretic separation of the active (reduced) and inactive (oxidized) forms of the purified toxin. Infect Immun (1976) 1.17
Adenine nucleotides promote dissociation of pertussis toxin subunits. J Biol Chem (1986) 1.17
The expression of vascular endothelial growth factor C and its receptors in non-small cell lung cancer. Br J Cancer (2001) 1.16
Enhancement of measles virus replication by actinomycin D. Jpn J Exp Med (1965) 1.15
Cloning and sequencing of the structural gene for the porin protein of Bordetella pertussis. Mol Microbiol (1991) 1.13
Microfilament dysfunction as a possible cause of intrahepatic cholestasis. Gastroenterology (1975) 1.13
In vitro inhibition of murine macrophage migration by Bordetella pertussis lymphocytosis-promoting factor. Infect Immun (1984) 1.12
Glial fibrillary tangles with straight tubules in the brains of patients with progressive supranuclear palsy. Neurosci Lett (1992) 1.12
Increased vascular endothelial growth factor and vascular endothelial growth factor-c and decreased nm23 expression associated with microdissemination in the lymph nodes in stage I non-small cell lung cancer. J Thorac Cardiovasc Surg (2000) 1.11
Biphasic effect of pertussis vaccine on serum insulin in mice. Infect Immun (1983) 1.11
Role of cholesterol in the action of cereolysin on membranes. Arch Biochem Biophys (1978) 1.11
Otological manifestations of leukemia. Laryngoscope (1973) 1.11
Pathology of sensorineural hearing loss in otitis media. Ann Otol Rhinol Laryngol (1972) 1.11
A bactericidal monoclonal antibody specific for the lipooligosaccharide of Bordetella pertussis reduces colonization of the respiratory tract of mice after aerosol infection with B. pertussis. Infect Immun (1992) 1.10
Purification and characterization of serotype 6 fimbriae from Bordetella pertussis and comparison of their properties with serotype 2 fimbriae. Infect Immun (1987) 1.10
Phase-shift markers in the genus Bordetella: loss of cytochrome d-629 in phase IV variants. Microbios (1981) 1.10